Scientific Advisory Board

The Scientific Advisory Board (SAB) is in an advisory capacity for the Board of Trustees and the Scientific Director both regarding scientific and technical issues. The SAB evaluates all scientific projects pursued at the FLI.

Members

Member  
Prof. Dr. Volker Haucke (Chair) Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin (FMP), Berlin, Germany
Prof. Dr. Sara Wickström (Co-Chair) Max Planck Institute for Molecular Medicine, Münster, Germany
Anne Ephrussi, PhD EMBL Heidelberg, Heidelberg, Germany
Prof. Dr. Marco Foiani IFOM-IEO Campus, Milan, Italy
Prof. Dr. Michaela Frye Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
Prof. Dr. med. Christian Hübner Friedrich Schiller University (FSU), Jena, Germany
Prof. Dr. Stephan Sigrist Free University of Berlin, Berlin, Germany
Prof. Dr. Anne-Katharina Simon Max Delbrück Center (MDC), Berlin, Germany
Sir Richard Treisman, PhD The Francis Crick Institute, London, UK
Dr. Nassos Typas EMBL, Heidelberg, Germany
Duygu Ucar, PhD The Jackson Laboratory, Bar Harbor, US
Prof. Dr. Jochen Wittbrodt Heidelberg University, Heidelberg, Germany